Literature DB >> 31033084

Changes in associations of prescription opioid use disorder and illegal behaviors among adults in the United States from 2002 to 20.

Carrie M Mintz1, Sarah M Hartz1, Jacob T Borodovsky1, Laura J Bierut1, Richard A Grucza1.   

Abstract

BACKGROUND AND AIMS: In the United States, the availability of prescription opioids has decreased in recent years. Whether there have been corresponding changes in the likelihood of people with prescription opioid use disorder (POUD) to engage in illegal behaviors related to drug use remains unknown. We examined changes in prevalence of illegal behaviors between people with and without POUD over time, and how transactions for obtaining opioids have changed among people with POUD over time.
DESIGN: Temporal trend analysis of repeated cross-sectional data.
SETTING: United States household dwelling population from all 50 states and District of Columbia. PARTICIPANTS: Adult subsamples from the 2002-14 National Survey of Drug Use and Health (n = 5393 people with POUD; n = 486 768 people without POUD). MEASUREMENTS: Outcome variables were selected illegal behaviors and sources of opioids used non-medically. POUD was defined using the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria. Time was treated as a continuous variable. The variable of interest for each illegal behavior analysis was the interaction between POUD diagnosis and time. Covariates included age, sex and race/ethnicity.
FINDINGS: During the 13-year period examined, the adjusted interaction odds ratio (AIOR) describing the change in association between POUD and selling illicit drugs increased by a factor of 2.41 [95% confidence interval (CI) = 1.56-3.71, P < 0.001]. Similar trends were noted for stealing (AIOR = 2.12, 95% CI = 1.31-3.44, P = 0.002) and for life-time history of arrest (AIOR = 1.53, 95% CI = 1.06-2.19, P = 0.021). People with POUD became less likely to receive opioids for free from friends and family [adjusted odds ratio (AOR) = 0.42, 95% CI = 0.25-0.71, P = 0.001] and more likely to buy them from friends and family (AOR = 3.29, 95% CI = 1.76-6.13, P < 0.001) from 2005 to 2014.
CONCLUSIONS: In the United States, against a backdrop of a decreasing prescription opioid supply, rates of some crimes potentially related to drug use increased among people with prescription opioid use disorder compared with those without prescription opioid use disorder from 2002 to 2014.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Crime; drug policy; illegal behavior; non-medical opioid source; opioid use disorder; prescription opioid use disorder

Mesh:

Substances:

Year:  2019        PMID: 31033084      PMCID: PMC6819203          DOI: 10.1111/add.14638

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   7.256


  24 in total

1.  Effect of abuse-deterrent formulation of OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

2.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

3.  Trends in opioid analgesic abuse and mortality in the United States.

Authors:  Richard C Dart; Hilary L Surratt; Theodore J Cicero; Mark W Parrino; S Geoff Severtson; Becki Bucher-Bartelson; Jody L Green
Journal:  N Engl J Med       Date:  2015-01-15       Impact factor: 91.245

4.  The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence - An assessment of demographic and substance use trends, United States, 2003-2014.

Authors:  Christopher M Jones
Journal:  Addict Behav       Date:  2016-08-17       Impact factor: 3.913

5.  Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

6.  The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.

Authors:  Curtis S Florence; Chao Zhou; Feijun Luo; Likang Xu
Journal:  Med Care       Date:  2016-10       Impact factor: 2.983

7.  Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.

Authors:  Traci C Green; Jennifer Clarke; Lauren Brinkley-Rubinstein; Brandon D L Marshall; Nicole Alexander-Scott; Rebecca Boss; Josiah D Rich
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 25.911

8.  Sources of opioid medication for misuse in older adults: results from a nationally representative survey.

Authors:  Ty S Schepis; Sean Esteban McCabe; Christian J Teter
Journal:  Pain       Date:  2018-08       Impact factor: 7.926

Review 9.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010.

Authors:  Kristen Kenan; Karin Mack; Leonard Paulozzi
Journal:  Open Med       Date:  2012-04-10
View more
  1 in total

Review 1.  An Evaluation of Opioid Use in Black Communities: A Rapid Review of the Literature.

Authors:  Ayana Jordan; Myra Mathis; Angela Haeny; Melissa Funaro; Dafna Paltin; Yusuf Ransome
Journal:  Harv Rev Psychiatry       Date:  2021 Mar-Apr 01       Impact factor: 3.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.